WAP
ABMD

Wealthcare Advisory Partners’s Abiomed Inc ABMD Stock Holding History

Wealthcare Advisory Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-42
Closed -$7K – 1615
2019
Q4 		$7K Hold
42
– – ﹤0.01% 1052
2019
Q3 		$7K Hold
42
– – ﹤0.01% 1018
2019
Q2 		$11K Hold
42
– – ﹤0.01% 890
2019
Q1 		$12K Hold
42
– – ﹤0.01% 784
2018
Q4 		$14K Hold
42
– – ﹤0.01% 717
2018
Q3 		$19K Hold
42
– – ﹤0.01% 699
2018
Q2 		$17K Buy
+42
New +$15.2K ﹤0.01% 719

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wealthcare Advisory Partners's ABMD Position: Q1 2020 in Review

Wealthcare Advisory Partners sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 42 shares — an estimated $7K sold.

Wealthcare Advisory Partners first reported a position in ABMD in Q2 2018 and held it in 7 quarters. The position peaked at $19K in Q3 2018. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Wealthcare Advisory Partners reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 42 Abiomed Inc shares in Q1 2020, an estimated $7K.
  • Wealthcare Advisory Partners first reported a position in Abiomed Inc in Q2 2018 and held it in 7 quarters.
  • Wealthcare Advisory Partners's Abiomed Inc position peaked at $19K in Q3 2018.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Wealthcare Advisory Partners's 13F filing for Q1 2020, filed 29 Apr 2020.